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Summary
For many opportunistic pathogens, it is unclear why their
virulence determinants and expression of pathogenic
behavior have evolved when damage or death of their host
offers no obvious selective advantage to microbial growth
or survival [1–3]. Many pathogens initiate interactions with
their host on mucosal surfaces and must compete with other
members of the microflora for the same niche. Here we
explore whether competitive interactions between microbes
promote the acquisition of virulence characteristics. During
model murine nasal colonization, Haemophilus influenzae
outcompetes another member of the local flora, Strepto-
coccus pneumoniae, by recruiting neutrophils and stimu-
lating the killing of complement-opsonized pneumococci [4].
For S. pneumoniae, resistance to opsonophagocytic killing
is determined by its polysaccharide capsule [5, 6]. Although
there are many capsule types among different S. pneumo-
niae isolates that allow for efficient colonization, virulent
pneumococci express capsules that confer resistance to
opsonophagocytic clearance. Modeling of interspecies inter-
action predicts that these more virulent S. pneumoniae will
prevail during competition withH. influenzae, even if produc-
tion of a capsule is otherwise costly. Experimental coloniza-
tion studies confirmed the increased survival of the more
virulent S. pneumoniae type during competition. Our find-
ings demonstrate that competition between microbes during
their commensal state may underlie selection for character-
istics that allow invasive disease.
Results and Discussion
Theoretical Modeling
One of the most basic and important evolutionary questions
posed about pathogens is why they harm the very sources of
their livelihoods, their hosts. Theoretical models (reviewed in
[7]) frequently assume that traits contributing to virulence
(reduced host fitness) provide a net selective advantage to the
pathogen within the host (e.g., increasing growth rate) and/or
in transmission to another host (e.g., increasing propagule
production). However, for many pathogens, these proposed
countervailing advantages of virulence are difficult to identify
either on the within- or among-host level [1–3]. For example, in
the case of the leading pathogen Streptococcus pneumoniae,*Correspondence: sam.brown@zoo.ox.ac.uk (S.P.B.), weiser@mail.med.
upenn.edu (J.N.W.)its most common disease states (pneumonia, otitis media, and
sepsis) are not contagious conditions and therefore represent
a dead end for the organism, especially when the result is the
rapid demise of the host [8]. Rather, transmission occurs from
the reservoir of pneumococci residing asymptomatically in the
nasopharynx during the organism’s commensal state [9].
However, among the >92 types of pneumococci expressing
structurally distinct capsular polysaccharides, only a few are
potentially virulent [10, 11]. So why has the pneumococcus
evolved or maintained the capacity for virulent, invasive
behavior through the expression of certain thick capsular poly-
saccharide coats?
To answer this question, we analyzed a simple model for
the within-host dynamics of two strains of pneumococcus
(resistant PR and susceptible PS) together with Haemophilus
influenzae (H) (Equations 1; see also Supplemental Results
available online). In the absence of the resistant strain (Equa-
tions 1 withPR = 0), we find that the immunomanipulative ability
of H. influenzae (captured by x > 1) increases the within-host
market share of H up to a point (when x > 1/h) where H can
completely outcompete a susceptible lineage of the pneumo-
coccus (Figure S1). The analysis of Equations 1 with PR = 0 is
consistent with a number of previous theoretical and experi-
mental studies suggesting that immunomanipulation can
aid a focal lineage (in our case, H) to exclude competitors
[4, 12–16] and is more generally consistent with the broad
phenomenon of interference competition in bacteria, exempli-
fied by bacteriocins [17].
We now ask, what happens if members of the susceptible
lineage (PS) become resistant to the killing (allelopathic) trait
of H? ‘‘Resistant nonkillers’’ are widely reported in studies of
bacteriocin-mediated interactions [18], and in our focal system
some pneumococcal types play the same role, being largely
resistant to the immunomanipulation generated by H. influen-
zae. We analyzed the full model (Equations 1) to allow for two
distinct lineages of pneumococci, the sensitive lineagePS, and
the resistant lineage PR. To describe the competitive interac-
tions among the two pneumococcal strains, we introduced
the competitive impact parameter a and the competitive sensi-
tivity parameter y of PR. When y and a equal 1, the two pneu-
mococcal strains are competitively equivalent in the absence
of H. If, however, the acquisition and maintenance of the
capsule come at some cost (relative to PS), then y > 1 > a,
and in the absence ofH,PS will always replacePR (a < 1 implies
an attenuated competitive impact of PR, and y > 1 implies an
increased susceptibility to competition in PR).
What happens when we allow the presence of all three line-
ages? The simplest scenario occurs ifH is strongly immunoma-
nipulative and is able to entirely exclude PS (x > 1/h; see
Figure S1). In this case, the resulting pure H equilibrium can
be invaded by rare PR if y < 1/h (Figure 1A), leading to a stable
coexistence between H and PR (Figure 1B). The second
scenario occurs if H is only moderately immunomanipulative,
leading first to a coexistence ofHandPS (x< 1/h; see Figure S1).
In this scenario, the resulting (H, PS) equilibrium can then be
invaded by rare PR if x > ðyð1 +hð12pÞÞ2 1Þ=ðhðy2pÞÞ (i.e.,
PR invades more readily as x increases; Figure 1A), resulting
in either (H, PR, PS) or (H, PR) coexistence (Figure 1B). Thus,
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Figure 1. Manipulation by Resident H. influenzae Increases Vulnerability to Host Invasion by Resistant Pneumococci PR
(A) Per capita growth rate of rare PR in a host at (H, PS) equilibrium (Figure S1), as a function of the strength of H immunomanipulation (x) and the cost of PR
capsule (y). The growth rate (dPR/dt)/PR is positive below the black line; darker shades indicate higher growth rates.
(B) The equilibrium (long-term trend) occupants of the nasal mucosa as a function of x and y. The region supporting nasal establishment by PR (dark gray
shades) is increasing with x. Lightest gray: costly capsule and effective immunomanipulation, only H is present. Light gray: costly capsule and weak
immunomanipulation,H and PS are present. Dark gray: cheaper capsule and weak immunomanipulation, all three strains are present. Darkest gray: cheaper
capsule and effective immunomanipulation, H and PR are present. Results are derived from Equations 1 in the Supplemental Results, with parameters
h = 0.5, p = 0.4, and a = 0.6. The exact invasion and equilibrium conditions are detailed in the Supplemental Results.
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absence of H, PR has an increasing advantage over PS as the
density and/or immunomanipulative behavior of H increases,
because it can resist the inflammatory response generated
by H. In general, selection favors PR over PS whenever
H(x-y)h > PS(y 2 1) + PR(1 2 a); thus, sufficient H can always
drive selection towardPR, given x> y (for a more complete anal-
ysis, see Supplemental Results). In the limiting case in whichPR
is rare and the cost of capsule is negligible (y tends to 1), the
more resistant lineage can invade for any amount of immuno-
manipulation, i.e., whenever x > 1.
Pneumococcal Strains for Experimental Comparison
We tested the model by determining whether pneumococcal
capsule type affects the outcome of immunomanipulation by
H. influenzae during experimental cocolonization. Pneumo-
coccal isolates of two capsular types were compared. Both
type 4 and type 23F pneumococci efficiently colonize the
upper airway of mice and induce a similar mild acute inflamma-
tory response characterized by the influx of neutrophils into
the nasal spaces following intranasal challenge [19]. Type 4
(isolate T4 representing a PR strain), but not type 23F (isolate
P1121 representing a PS strain), pneumococcus causes inva-
sive infection following intranasal challenge of immunocompe-
tent mice [19, 20]. Additionally, there is a >108-fold difference
in the LD50 for strains of these types following systemic chal-
lenge [21]. However, the greater virulence of PR is associated
with a cost during colonization, as revealed during intraspe-
cies competition with PS (Figure 2A). In contrast, there was
no significant effect onPS from the competition withPR. There-
fore, we determined whether the colonization deficit in PR
would be offset by its potential advantage in the context of co-
colonization by H. influenzae, as predicted in the theoretical
model.To address this question, we generated isogenic strains in
which the capsule type was switched (type 4 switched to type
23F to generate PR/S and type 23F switched to type 4 to
generate PS/R) to control for the potentially confounding
effect of genetic background. A sensitive capture ELISA was
used to confirm thatPR/S andPS/R produce equivalent levels
of capsular polysaccharide to the isotypic strain (data provided
in Table S1). When tested for the ability to cause bacteremic
infection, the competitive index (CI) for PS/R/PS was >6.0,
confirming the contribution of capsule type rather genetic
background to virulence.
The Effect of Capsule Type on Pneumococcal Survival
during Experimental Competition
The density of colonizing H. influenzae (H) is not affected by
the presence of S. pneumoniae. However, cocolonization of
H with PS results in a steep decline in density of PS in the upper
airways within 24 hr postinoculation (Figure 2B). In contrast,
although PR alone colonized at similar levels to PS alone in
the absence of the competitor, coinoculation with H had no
significant effect on its colonization. Switching of the capsule
type from PS/R was sufficient to eliminate its susceptibility to
competition, whereas switching the capsule type from PR/S
was sufficient to render it sensitive to competition by H. These
results confirmed that capsule type alone is sufficient to
dictate the outcome of a competitive interaction with another
species.
Loss of Pneumococci during Competition Requires
Opsonophagocytosis
Next, we explored the host mechanisms selecting for capsule
type during interspecies competition. In C57BL/6 mice, sys-
temic depletion of neutrophils is sufficient to eliminate the
competitive effect of H. influenzae on type 23F pneumococci
Figure 3. The Immunomanipulative Effect of H. influenzae on S. pneumo-
niae Requires Opsonophagocytosis and Is Dependent on Capsule Type
(A) The density of PS in the upper respiratory tract was determined at 24 hr
postintranasal inoculation with the PS alone (gray bars) or together with
(open bars) H. influenzae (H). Colonization density was compared in
C57BL/6 mice (WT) treated with RB6-8C5 (intraperitoneal [i.p.] antibody
treatment to deplete neutrophil-like cells), in cobra venom factor (i.p. cobra
venom factor pretreatment to deplete complement), and in Mac12/2 (CD11b/
CD18) mice. Values represent the mean6SD for 4–11 animals per condition.
(B) The relationship of capsule type to survival in opsonophagocytic killing
assays. Neutrophil-enriched peritoneal exudate cells (PECs) were obtained
from mice pretreated by i.p. administration of casein. Survival of theS. pneu-
moniae strains with type 23F (gray bars, PS and PR/S) or type 4 (black bars,
PR and PS/R) capsules is shown relative to controls without neutrophil-
enriched PECs. Values representR3 independent determinations in dupli-
cate 6 SD.
*p < 0.05, **p < 0.01, ***p < 0.001. NS denotes nonsignificant.
Figure 2. Competition between Pneumococcal Isolates of Different Sero-
types and Effect of Capsule Type on Immunomanipulation
(A) In the absence of H. influenzae, PR is competitively inferior to PS. The
density of S. pneumoniae (P) in upper respiratory tract lavages was deter-
mined at 24 hr postintranasal inoculation. Colonization density was
compared for P strains with type 23F (gray bars, PS) or type 4 (black bars,
PR) capsules, alone or together (coinoculated P strain indicated in paren-
theses).
(B) The density ofS. pneumoniae (P) in the upper respiratory tract was deter-
mined at 24 hr postintranasal inoculation, alone without (filled bars) or
together with (open bars) H. influenzae (H). Colonization density was deter-
mined for S. pneumoniae strains with type 23F (gray bars, PS and PR/S) or
type 4 (black bars, PR and PS/R) capsules. (Controls PS and PR shown in A
are also shown here to allow for comparison to groups with H.)
Values represent the mean 6 standard deviation (SD) for 6–17 animals per
condition. *p < 0.05, **p < 0.01, ***p < 0.001. NS denotes nonsignificant.
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longer observed in mice in which complement activity was
depleted by prior treatment with cobra venom factor (CoVF).
There was also no competitive effect in mice lacking the
complement C3 receptor Mac-1 (CD11b/CD18). Together,
the requirement for neutrophils, complement, and the Mac-1
provided evidence that the loss of PS during cocolonization
was dependent on opsonophagocytic clearance.
To test whether capsule type could account for differences
in opsonophagocytic clearance, we compared each of the
strains in an ex vivo killing assay using elicited murine neutro-
phils and serum as a source of complement (Figure 3B). Killing
in this assay was dependent on the capsule type rather than
genetic background. Strains expressing the avirulent type 23F
capsule type (PS and PR/S) were sensitive to the effects of
neutrophils and complement. In contrast, no killing was de-
tected in strains expressing the virulent type 4 capsule type
(PR and PS/R). Thus, the outcome of interspecies competition
requires opsonophagocytosis and correlates with relative re-
sistance to killing by this mechanism. Because capsule type
impacts sensitivity to complement deposition and subsequent
phagocytosis, it may have a profound effect on the outcome of
mucosal competition and, consequently, the selection for
more resistant or virulent types [6].The Effect of H. influenzae on Capsule-Dependent Survival
during Experimental Competition
Next, we tested our model by directly competing the isogenic
virulent (PS/R) and avirulent (PS) pneumococcal strains in the
presence of the immunomodulator, H. influenzae (H) (three-
strain experiment, Figure 4A). In comparison to controls
without H, colonization density was significantly enhanced for
PS/R and inhibited for PS (p < 0.05 and p < 0.01, respectively).
The mean competitive index (strain ratio after in vivo competi-
tion, normalized by ratio in inoculum) for PS/R /PS was signif-
icantly <1 without H (p < 0.001, t test compared to null expec-
tation of CI = 1). To test the model prediction that increasing
densities of H will change the magnitude of selection on
capsule type, we stratified mice by their colonization density
with H. influenzae. For mice colonized by H. influenzae at a
higher (>103 cfu/ml) density, the mean competitive index for
PS/R /PS was significantly >1 (p < 0.05, t test compared to
null expectation of CI = 1), supporting our principal prediction
that sufficient densities ofH can generate positive selection for
capsule virulence traits in the pneumococcus. Competition
between nonisogenic, clinical isolates PS and PR was more
Figure 4. When S. pneumoniae with Different Capsules Compete, Immuno-
modulation by H. influenzae Enhances Colonization by the More-Virulent
Strain and Inhibits Colonization for the Less-Virulent Strain
(A and B) Mice were challenged with equal inocula of 2 isogenic S. pneumo-
niae strains with type 23F (PS) and type 4 (PS/R) capsules (A) or 2 S. pneu-
moniae clinical isolates with type 23F (PS) and type 4 (PR) capsules (B), and
the density of each strain was determined in upper respiratory tract lavages
at 24 hr postinoculation. Each symbol represents the competitive index
value for an individual animal without (solid symbols) or with (open symbols)
H. influenzae. The competitive index was calculated based on the ratio of
each strain in nasal lavages compared to the ratio in the inoculum. The
horizontal line is at a value of 1 (log10 = 0).
(A) A value less than 1 indicates that PS outcompetes PS/R, and a value
greater than 1 indicates that PS/R outcompetes PS.
(B) A value less than 1 indicates that PS outcompetes PR, and a value greater
than 1 indicates that PR outcompetes PS.
Competitive index values were also stratified for animals with high (>103 cfu/
ml) density of colonization by H. Mean values for each condition are indi-
cated by horizontal bars. ***p < 0.001. NS denotes nonsignificant.
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index (PR /PS) was also observed during immunomodulation
by H. influenzae (Figure 4B, p < 0.001). These experimental
results demonstrate that immunomodulation by H. influenzae
can dictate the relative capsule-type-dependent fitness of
pneumococcal strains.
Within-Host Ecology and the Evolution of Virulence
The impact of within-host competition on the evolution of viru-
lence has been the subject of a diverse range of models,
offering contrasting explanations for either an increase or a
decrease in virulence as within-host diversity increases [22].
A key distinction separating our work from nearly all theoreticalstudies of virulence evolution in multiple infected hosts is that
we examine multispecies infections (as opposed to multiple
strains differing only in a focal virulence trait [22]). A major
consequence of this distinction is that the direction of selec-
tion on virulence traits no longer simply depends on the
number of coinfecting strains but now depends very much
on their identity. In the context of our current study, we show
that more invasive—and therefore more virulent—pneumo-
coccal capsule variants can be selected for within the mucosal
environment, but only if there is sufficient burden of an immu-
nomanipulative coinfecting microbe (Figure 4A).
Because different capsule types are antigenically distinct
and the immunodominant constituent of the pneumococcal
surface, it has been assumed that the diversity of capsular
types arose to escape immune pressure in the host [23].
However, only a few capsule types generally account for the
overwhelming majority of both carriage and disease isolates,
for unknown reasons [11]. There is a metabolic cost to produce
large amounts of capsular polysaccharide, and the capsule
may obscure surface molecules, such as adhesins, needed to
interact with the host [24–26]. We suggest that the diversity of
capsule types will in part be explicable by variation among the
flora. Thus, in situations in which the competitor (H) is highly
prevalent and/or highly immunomanipulative (high H and/or
high x), we anticipate that selection would favor thicker capsule
types that are more resistant to clearance by opsonophagocy-
tosis. Thus, our observations provide an explanation for the
evolution of potentially costly capsule types more resistant to
acute inflammatory responses that promote the virulent
behavior of an organism with an otherwise commensal lifestyle.
Our findings provide a theoretical and experimental demon-
stration that the capsule virulence determinant confers a selec-
tive advantage during colonization by allowing for persistence
during mucosal inflammation induced by competitive interac-
tions among the flora. This paradigm offers a possible expla-
nation for the disproportionate prevalence of the few pneumo-
coccal types associated with invasive disease [27]. Like the
pneumococcus, many opportunist pathogens must become
established at host sites in the presence of other microbes.
We propose that events during within-host competition may
underlie the benefit of virulence determinants that either
induce or protect against the host’s inflammatory responses.Experimental Procedures
Theoretical Model
The results in Figure 1 are derived from the following differential equations,
tracking the densities of H. influenzae (H), and two strains of S. pneumoniae
(sensitive [PS] and resistant [PR]):
dH=dt=Hð12H2p PS2p a PRÞ
dPS=dt=PSð12h x H2PS2 a PRÞ
dPR=dt=PRð12h y H2 y PS2PRÞ (Equations 1).
For detailed presentation and analysis, see Supplemental Results. The
parameters p, a, h, x, and y capture the competitive interactions among
the three strains. p is the competitive impact of PS on H, and h is the impact
of H on PS in the absence of immunomanipulation (p = h = 1 would imply
competitive equivalence; we assume p < 1, h < 1, ensuring coexistence
between H and PS when x = 1). x captures the additional impact of H on
PS because of immunomanipulation (x = 1 would imply no immunomanipu-
lation; we assume x > 1). y and a capture the competitive abilities of PR rela-
tive to PS. We assume y > 1 (PR is more sensitive to competition from the
other strains) and a < 1 (PR has an attenuated competitive impact on the
other strains).
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Six- to eight-week-old mice used in the study were housed in accordance
with Institutional Animal Care and Use Committee protocols. Mouse strains
used for this study included C57BL/6 (WT) and B6.129S4-Itgamtm1Myd/J
(Mac-1 [CD11b/CD18]-deficient mice, Jackson Laboratories), with a tar-
geted mutation in the gene for integrin alpha M or complement receptor
type 3 [28]. Neutrophils from these animals are deficient at phagocytosing
complement-opsonized particles and in several Fc-mediated functions.
Briefly, groups of at least 5 mice per condition were inoculated intrana-
sally with 1 3 107 cfu of phosphate-buffered saline (PBS)-washed, midlog
phase H. influenzae or S. pneumonia, each applied separately to each naris
in 10 ml. Pneumococcal strains and characteristics are provided in the
Supplemental Experimental Procedures. Twenty-four hours postinocula-
tion, the animal was sacrificed, the trachea was cannulated, and 200 ml of
PBS was instilled. Lavage fluid was collected from the nares for determina-
tion of viable counts of bacteria in serial dilutions plated on selective
medium, containing antibiotics to inhibit the growth of contaminants. To
select for H. influenzae (H636), we used streptomycin at a concentration
of 100 mg/ml. Neomycin, 20 mg/ml, or erythromycin, 1 mg/ml, was used to
select for S. pneumonia either P1121 and its derivatives or TIGR4 and its
derivatives, respectively.
Statistical Analysis
For single-factor analyses, statistical comparisons of colonization between
groups were made using either the Kruskal-Wallis test with Dunn’s post test
or t tests, as appropriate.
For statistical comparisons of two or more variables simultaneously, two-
way analysis of variance (ANOVA) was used to determine whether the inter-
action between these variables was significant. If the interaction between
variables was significant by two-way ANOVA, Bonferroni post tests were
used to determine each variable’s effect on colonization outcome. If there
was no statistically significant interaction between variables, colonization
outcomes were compared using one-factor analyses, as described above.
For comparisons of competitive indices (calculated as the ratio of strains
in nasal lavages compared to the ratio of strains in the inoculum), log-trans-
formed values were analyzed using ratio t tests.
Supplemental Information
Supplemental Information includes Supplemental Data, Supplemental
Experimental Procedures, one figure, and one table and can be found
with this article online at doi:10.1016/j.cub.2010.05.051.
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